Diagnosing and managing childhood absence epilepsy by telemedicine

Area of Science:

• Pediatric Neurology
• Epilepsy Management
• Telemedicine in Healthcare

Background:

• Childhood absence epilepsy (CAE) diagnosis traditionally relies on clinical history, hyperventilation tests, and electroencephalography (EEG).
• The COVID-19 pandemic necessitated a shift towards telemedicine for non-emergent pediatric neurology consultations.
• Remote diagnostic methods became crucial for continued patient care.

Purpose of the Study:

• To evaluate the feasibility of diagnosing and managing childhood absence epilepsy (CAE) via telemedicine.
• To assess the effectiveness of remote hyperventilation testing in CAE diagnosis.
• To document the impact of early treatment initiated during telemedicine visits.

Main Methods:

• Utilized telemedicine for pediatric outpatient evaluations, including remote hyperventilation testing.
• Diagnosed children with CAE based on history and remote positive hyperventilation results.
• Initiated CAE treatment for some patients before routine EEG confirmation.

Main Results:

• Successfully diagnosed CAE in a series of children using telemedicine and remote hyperventilation tests.
• Observed significant seizure reduction in children treated early based on telemedicine diagnosis.
• Demonstrated the practical application of telemedicine for CAE management.

Conclusions:

• Telemedicine is a feasible and effective tool for diagnosing and managing childhood absence epilepsy (CAE).
• Remote hyperventilation testing can support CAE diagnosis in a telemedicine setting.
• Early treatment guided by telemedicine evaluations can lead to positive patient outcomes.